Pharmafile Logo

Clinial Trials

- PMLiVE

NICE relents on Kadcyla after Roche pricing negotiations

HER2-positive breast cancer therapy to be made available on the NHS in England

EU flag

Medicxi aims to plug funding gap for European biotech

Fund also backed by Novartis, Alphabet’s Verily unit and the EIF

- PMLiVE

Multipharma launches Inceptua Medicines Access

The group will be split into three sub-divisions

- PMLiVE

Healthcare Heroes

The people behind the curtain

- PMLiVE

Asian patient groups give pharma above average marks for reputation

PatientView survey finds 49% believe sector has a good corporate reputation

Avita Medical appoints CEO

Dr Michael Perry joins from Novartis

- PMLiVE

Edelman UK appoints Kate Hawker as healthcare MD

She joins the communications agency from Burson-Marsteller

- PMLiVE

RB and Lions Health hold air pollution innovation hack

The second annual event will focus on China

Google’s Verily backs $300m European life sciences fund

The Medicxi fund for drug development firms also attracts support from Novartis

Can Cinderella save us?

Basilea bags $72m upfront from Pfizer for antifungal license

Pfizer will also pay $427m in future milestone payments for Cresemba

- PMLiVE

NICE rejects Pfizer’s antibody drug for leukaemia

Trial shows no survival benefit from Besponsa compared to current treatment

- PMLiVE

Hanover Health picks up a trio of new accounts

Adds Cambridge Medical Robotics, OMRON and Consultant Connect to its client roster

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links